Publication Name	World Journal of Hepatology
Manuscript ID	22210
Country	United States

Received	2015-08-20 08:40
Peer-Review Started	2015-08-22 18:10
To Make the First Decision	2015-10-27 11:14
Return for Revision	2015-10-30 15:37
Revised	2015-10-30 23:45
Second Decision	2015-12-07 09:26
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-12-18 17:06
Articles in Press	2015-12-18 17:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-02 15:35
Publish the Manuscript Online	2016-01-07 12:14

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Treatment strategies for chronic hepatitis C prior to and following liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Ryan B Perumpail, Thomas A Hahambis, Avin Aggarwal, Zobair M Younossi and Aijaz Ahmed
Funding Agency and Grant Number
Corresponding Author	Ryan B Perumpail, MD, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite 210, Palo Alto, CA 94304, United States. rperumpail@gmail.com
Key Words	Hepatitis C virus; Liver transplantation; Direct acting antivirals; Sustained virologic response
Core Tip	The historic standard of care during the interferon era of hepatitis C virus (HCV) therapy was expectant management-initiation of antiviral therapy in the setting of documented disease progression following liver transplantation. With the advent of new direct acting antiviral (DAA) therapies for HCV, the paradigm of expectant treatment for recurrent HCV infection post-liver transplantation (LT) is shifting. The safety, tolerability, and efficacy of DAAs, even among the sickest patients with advanced liver disease, enables treatment of HCV in the pre-transplant setting among LT waitlist registrants. Emerging data support preemptive therapy with DAAs in liver transplant recipients as the preferred approach.
Publish Date	2016-01-07 12:14
Citation	Perumpail RB, Hahambis TA, Aggarwal A, Younossi ZM, Ahmed A. Treatment strategies for chronic hepatitis C prior to and following liver transplantation. World J Hepatol 2016; 8(1): 69-73
URL	http://www.wjgnet.com/1948-5182/full/v8/i1/69.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i1.69

Full Article (PDF)	WJH-8-69.pdf
Full Article (Word)	WJH-8-69.doc
Manuscript File	22210-Review.docx
Answering Reviewers	22210-Answering reviewers.pdf
Audio Core Tip	22210-Audio core tip.wma
Conflict-of-Interest Disclosure Form	22210-Conflict-of-interest statement.pdf
Copyright License Agreement	22210-Copyright assignment.pdf
Peer-review Report	22210-Peer-review(s).pdf
Scientific Misconduct Check	22210-Scientific misconduct check.pdf
Scientific Editor Work List	22210-Scientific editor work list.pdf